Skip to content
logo-orbit-white
Main Menu
  • Training Courses
    • RRI Training
    • Trusted Research
    • Design of Ethical AI Systems
    • Stakeholder Engagement
    • Data Governance
    • Ethical Hackathons
    • Responsible Quantum Technologies
    • Environmentally Sustainable Research
  • Resources & Tools
    • AREA 4P Framework
    • The Keys of RRI
    • About RRI Maturity
    • Self Assessment Tool
    • Self Assessment Results
    • RRI Maturity
    • RRI Maturity Results
    • Action Plan
    • Action Plan Results
  • Services
  • News
  • Contact
Login

RRI Training

I

Trusted Research Training

I

Ethical AI Systems Training

I

Stakeholder Engagement

I

Data Governance

I

Sustainable Research

  • About ORBIT
    • AREA 4P Framework
    • The Keys of RRI
    • Employment Opportunities
  • Tools
  • Contact
  • Account
    • Workshop Hub
    • Your Courses
    • Organisation RRI Maturity Archive
    • RRI Intensity Level Archive
    • Your Action Plans
    • Delete Your Account
  • Embrace Course Booking
  • Journal
  • Toggle website search
Read more about the article Bharat Biotech International Limited Moves Towards Initial Public Offering

Bharat Biotech International Limited Moves Towards Initial Public Offering

Kolkata: Bharat Biotech International Limited, a prominent vaccine manufacturer in India, is reportedly preparing to engage with capital markets. The firm is contemplating a substantial initial public offering (IPO) that…

Read more about the article Fargo-Moorhead: A Hub of Economic Diversity with a Dozen Billion-Dollar Enterprises

Fargo-Moorhead: A Hub of Economic Diversity with a Dozen Billion-Dollar Enterprises

FARGO — Fargo-Moorhead is distinguished by the presence of a dozen billion-dollar enterprises, a fact that economic leaders attribute not only to the scale of these corporations but also to…

Read more about the article SIMRIS_B: Revenue Decline and Liquidity Challenges Amid Biotech Transition

SIMRIS_B: Revenue Decline and Liquidity Challenges Amid Biotech Transition

SIMRIS_B has reported a significant drop in net revenue, which decreased by 44% year-over-year. Despite improvements in EBITDA and EBIT, the company is grappling with negative equity and cash flow…

Read more about the article Generate Biomedicines Achieves Fundraising Milestone Amidst Share Price Decline

Generate Biomedicines Achieves Fundraising Milestone Amidst Share Price Decline

Generate Biomedicines has successfully achieved its fundraising objective during its initial public offering (IPO), which took place on February 27, 2026. The IPO was priced within the anticipated range, thereby…

Read more about the article Ensysce Biosciences Sees Share Surge Amid Strategic Review

Ensysce Biosciences Sees Share Surge Amid Strategic Review

Ensysce Biosciences (NASDAQ:ENSC) has witnessed a significant increase in its share price on Friday, following the announcement of a strategic review aimed at enhancing shareholder value. On Wednesday, the company…

Read more about the article Strategic Collaboration Between WuXi XDC and Earendil Labs to Enhance ADC Development

Strategic Collaboration Between WuXi XDC and Earendil Labs to Enhance ADC Development

SHANGHAI, 27 February 2026 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a prominent global Contract Research, Development, and Manufacturing Organization (CRDMO) that excels in antibody-drug conjugates…

Read more about the article Key Players in Pharma, Biotech, and Health Sector Featured on the 2026 Changemakers List

Key Players in Pharma, Biotech, and Health Sector Featured on the 2026 Changemakers List

In an important announcement, CNBC's Julia Boorstin has revealed the names of significant contributors to the pharmaceutical, biotechnology, and health sectors included in the 2026 Changemakers list. This list acknowledges…

Read more about the article Asahi Kasei Acquires Aicuris for €780 Million to Strengthen Antiviral Portfolio

Asahi Kasei Acquires Aicuris for €780 Million to Strengthen Antiviral Portfolio

Asahi Kasei, the Japanese pharmaceutical company, has entered into an agreement to acquire the German biotechnology firm Aicuris. This strategic move is aimed at enhancing Asahi Kasei's capabilities in antiviral…

  • Go to the previous page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14

Course Information

Help & Information

  • About ORBIT
  • Terms & Conditions
  • Privacy Policy
  • Data Breach Policy
  • Contact
  • About ORBIT
  • Terms & Conditions
  • Privacy Policy
  • Data Breach Policy
  • Contact

Contact Us

  • contact@orbit-rri.org
  • @orbitrri
  • @orbitrri

Training & Workshops

AI Empowerment

Stakeholder Engagement

Trusted Research

Data Governance

Ethical Hackathons

RRI Training

Responsible Quantum Technologies

Environmentally Sustainable Research

Design of Ethical AI Systems

  • About ORBIT
  • Terms & Conditions
  • Privacy Policy
  • Data Breach Policy
  • Contact
Copyright 2023 - ORBIT RRI a not for profit company.

By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.

Accept